CYBB
CYBB (cytochrome b-245 beta chain), also known as NOX2, GP91-PHOX and NADPH oxidase 2, is the catalytic subunit of the phagocyte NADPH oxidase complex. It transfers electrons from cytosolic NADPH to oxygen to generate the superoxide anion. Browse Assay Genie's current range of CYBB research reagents below, or read on for the biology behind the target.
CYBB is the catalytic subunit of the phagocyte NADPH oxidase complex. It mediates the transfer of electrons from cytosolic NADPH to molecular oxygen (O2), producing the superoxide anion (O2-). In the activated complex, electrons pass first from NADPH to flavin adenine dinucleotide (FAD) and then via two heme molecules to oxygen, so that superoxide is formed through an outer-sphere reaction.
Activation depends on assembly. Cytosolic subunits of the NADPH oxidase complex join the core complex at the plasma membrane or the phagosomal membrane. This process is initiated by phosphorylation-dependent binding of the cytosolic subunit NCF1 (p47-phox) to the C-terminus of CYBA (p22-phox). Interaction with NRROS impairs assembly of the complex. Cytochrome b-245 is composed of the CYBA (alpha) and CYBB (beta) chains, and has been proposed as a primary component of the microbicidal oxidase system of phagocytes. UniProt records the CYBB protein in the cell membrane, and HGNC places the CYBB gene in the flavoprotein group, within the NADH oxidase family. The mouse ortholog is Cybb.
The gene and protein have several names: GP91-PHOX, GP91PHOX, p91-PHOX, NOX2 and NADPH oxidase 2. The previous HGNC names, cytochrome b-245, beta polypeptide and chronic granulomatous disease, reflect its disease association. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In CGD, phagocyte NADPH oxidase activity is decreased. Neutrophils can phagocytose bacteria but cannot kill them in the phagocytic vacuoles, because the cell cannot increase its respiration and deliver activated oxygen into the vacuole.
CYBB is a primary component of the microbicidal oxidase system of phagocytes, making it central to studies of how neutrophils kill ingested bacteria.
CYBB deficiency is one of five described biochemical defects associated with CGD, so the protein is a focus for studying impaired phagocyte killing.
As the catalytic subunit that passes electrons from NADPH through FAD and two hemes to oxygen, CYBB is a model for regulated superoxide production.
CYBB function depends on assembly with CYBA and cytosolic subunits such as NCF1, and is impaired by NRROS, which makes it useful for studying complex regulation.
CYBB is the catalytic subunit of the phagocyte NADPH oxidase complex. It transfers electrons from cytosolic NADPH to FAD, then through two heme molecules to oxygen, producing superoxide. This activity supports the microbicidal function of phagocytes and depends on assembly of cytosolic subunits with the core complex.
CYBB is also called NOX2, NADPH oxidase 2, GP91-PHOX, GP91PHOX and p91-PHOX. Earlier HGNC names include cytochrome b-245, beta polypeptide and chronic granulomatous disease, and CGD is listed as a previous symbol. It forms cytochrome b-245 together with the CYBA chain.
CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease, in which neutrophils engulf bacteria but cannot kill them. The mouse ortholog is Cybb. Check the datasheet of any product for its validated reactivity.
Partner subunits and regulators of the phagocyte NADPH oxidase complex, plus related targets in phagocyte redox biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P04839; product specifications from Assay Genie datasheets.